OncoResponse
ResearchView the employees at
OncoResponse-
Kevin Green Senior Research Associate
-
Rising Star
Peter Probst Senior Director Immuno-Oncology at OncoResponse Inc.-
Seattle, Washington, United States
-
Top 10%
Clifford Stocks Chief Executive Officer at OncoResponse, Inc.-
Seattle
-
Top 5%
Ramya Chandrasekaran Senior Scientist, Immuno-Oncology & Antibody Discovery-
Seattle, Washington, United States
-
Rising Star
Kate Harrop Vice President, Clinical Operations at OncoResponse Inc.-
Seattle, Washington, United States
-
Rising Star
Overview
OncoResponse is a clinical stage, privately held immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite cancer responders. In a broad strategic alliance with MD Anderson Cancer Center, OncoResponse deploys a proprietary B-cell discovery platform to identify and develop novel therapeutics targeting the tumor microenvironment. The company’s lead candidate, OR2805, has entered clinical studies with a unique and transformative approach to the advancement of cancer therapeutics. OncoResponse is based in Seattle, Washington.
-